Skip to content

Medical-device intelligence

Nanosphere, Inc.: FDA clearances and recalls

Research Nanosphere, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

15 clearance records and 12 recall records in the covered releases, across 1 source company names and 10 product codes. Dated history runs from Sep 17, 2007 to Sep 4, 2015.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

27 matching records
Device / recordCompany in FDA recordSourceSource date
Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex)K143653 · OCCNanosphere, Inc.510(k)Sep 4, 2015FDA decision date
Verigene BC-GP Kit (Catalog number 20-005-018); 1) 20 Verigene BC-GP Test Cartridges; are qualitative multiplexed in vitro diagnostic tests for s…Z-2735-2014 · PAMNanosphere, Inc.RecallSep 30, 2014FDA classification date
Verigene BC-GN Kit (Catalog number 20-005-021); 1) 20 Verigene BC-GN Test Cartridges; are qualitative multiplexed in vitro diagnostic tests for s…Z-2736-2014 · PENNanosphere, Inc.RecallSep 30, 2014FDA classification date
The Verigene Gram Negative Blood Culture Nucleic Acid Test (BC-GN), performed using the sample-to-result Verigene System, is a qualitative multip…Z-2681-2014 · PENNanosphere, Inc.RecallSep 23, 2014FDA classification date
The Verigene Clostridium difficile Nucleic Acid Test (CDF) is a qualitative, multiplexed in vitro diagnostic test for the rapid detection of toxi…Z-2682-2014 · OZNNanosphere, Inc.RecallSep 23, 2014FDA classification date
The Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-UP) performed using the sample-to-result Verigene System is a qualitative, multipl…Z-2683-2014 · PAMNanosphere, Inc.RecallSep 23, 2014FDA classification date
The Verigene Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene System is a qualitative nucleic acid multiplex test intended to simul…Z-2684-2014 · OCCNanosphere, Inc.RecallSep 23, 2014FDA classification date
The Verigene Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common …Z-2685-2014 · PCHNanosphere, Inc.RecallSep 23, 2014FDA classification date
Verigene CYP2C19 Nucleic Acid Test (CYP2C19 Test). Each CYP2C19 kit consists of 20 Verigene CYP2C19 Nucleic Acid Test Cartridges and 20 Verigene…Z-2559-2014 · NTINanosphere, Inc.RecallAug 28, 2014FDA classification date
Verigene BC-GN Test Kit (Catalog number 20-005-021) includes: 1) 20 Verigene BC-GN Test Cartridges. Each Test Cartridge comes preloaded with all …Z-2236-2014 · PENNanosphere, Inc.RecallAug 14, 2014FDA classification date
Nanosphere Verigene Each CDF test consists of a Verigene CDF Nucleic Acid Test Kit and a Verigene CDF Amplification Reagent Kit. The Veri…Z-2168-2014 · OZNNanosphere, Inc.RecallAug 8, 2014FDA classification date
Verigene Gram-Negative Blood Culture Nucleic Acid Test (BC-GN), performed using the sample-to-result Verigene System, is a qualitative multiplexe…Z-2170-2014 · PENNanosphere, Inc.RecallAug 8, 2014FDA classification date
VERIGENE ENTERIC PATHOGEN NUCLEIC ACID TEST ( EP)K140083 · PCHNanosphere, Inc.510(k)Jun 20, 2014FDA decision date
VERIGENE GRAM NEGATIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GN)K132843 · PENNanosphere, Inc.510(k)Jan 8, 2014FDA decision date
VERIGENE C. DIFFICILE NUCLEIC ACID TEST (CDF)K123197 · OZNNanosphere, Inc.510(k)Dec 5, 2012FDA decision date
VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)K120466 · NTINanosphere, Inc.510(k)Nov 6, 2012FDA decision date
VERIGENE GRAM-POSITIVE BLOOD CULTURE (GC-GP) NUCLEIC ACID TESTK122514 · PAMNanosphere, Inc.510(k)Sep 19, 2012FDA decision date
VERIGENE STAPHYLOCOCCUS BLOOD CULTURE NUCLEIC ACID TEST (BC-S)K112424 · NQXNanosphere, Inc.510(k)Dec 16, 2011FDA decision date
VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST +(RVNAT+)K103209 · OCCNanosphere, Inc.510(k)Jan 10, 2011FDA decision date
VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST ON THE VERIGENE SP SYSTEMK093337 · OCCNanosphere, Inc.510(k)Nov 17, 2009FDA decision date
VERIGENE SYSTEM, VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TESTK092957 · OCCNanosphere, Inc.510(k)Oct 21, 2009FDA decision date
VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST ON THE VERIGENE SP SYSTEM (RVNATSP)K092566 · OCCNanosphere, Inc.510(k)Oct 9, 2009FDA decision date
VERIGENE CFTR NUCLEIC ACID TEST AND VERIGENE CFTR POLYT NUCLEIC ACID TESTK083294 · NUANanosphere, Inc.510(k)Jul 24, 2009FDA decision date
VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TESTK083088 · OCCNanosphere, Inc.510(k)May 1, 2009FDA decision date
Warfarin Metabolism Nucleic Acid Test Cartridge; Part Number: 20-006-002; an in vitro diagnostic drug metabolizing enzyme genotyping system; Nano…Z-1383-2008 · ODWNanosphere, Inc.RecallMar 31, 2008FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗